Atea Pharmaceuticals, Inc. (AVIR) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-23

Atea Pharmaceuticals, Inc. (AVIR) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-23. 2 Form 8-K material event filings were reported by AVIR in the last 90 days. InsiderAlpha tracks every AVIR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Atea Pharmaceuticals, Inc. (AVIR)

SEC CIK0001593899

90-Day SEC Filing Activity

Form 4 filings (90d)10
Form 8-K filings (90d)2
Latest Form 4 filing2026-06-23

Recent AVIR Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Lucidi BrunoInsiderM — Option exercise29.6K$0.00—SEC
Adams Jerome M.InsiderM — Option exercise29.6K$0.00—SEC
Murphy Polly A.InsiderM — Option exercise29.6K$0.00—SEC
Polsky BruceInsiderM — Option exercise29.6K$0.00—SEC
Duncan Barbara GayleInsiderM — Option exercise29.6K$0.00—SEC
BERGER FRANKLIN MInsiderM — Option exercise29.6K$0.00—SEC
Murphy Polly A.InsiderP — Open-market purchase6.1K$4.17$25KSEC
Corcoran AndreaSee RemarksM — Option exercise60.0K$1.24$74KSEC
Sommadossi Jean-PierrePresident, CEO, and ChairmanM — Option exercise300.0K$1.24$372KSEC
Horga Maria ArantxaChief Medical OfficerF — Tax withholding / forfeiture16.1K$4.24$68KSEC
Sommadossi Jean-PierrePresident, CEO, and ChairmanM — Option exercise273.0K——SEC
Sommadossi Jean-PierrePresident, CEO, and ChairmanF — Tax withholding / forfeiture106.1K$4.24$450KSEC
Horga Maria ArantxaChief Medical OfficerM — Option exercise51.3K——SEC
Foster WayneEVP, Chief Accounting OfficerM — Option exercise41.3K——SEC
Foster WayneEVP, Chief Accounting OfficerF — Tax withholding / forfeiture12.1K$4.24$51KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Atea Pharmaceuticals, Inc. (AVIR). Updated in real time as new filings are submitted to the SEC.

Most-Active AVIR Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Murphy Polly A.6$51K
Duncan Barbara Gayle4—
Adams Jerome M.4—
Polsky Bruce4—
BERGER FRANKLIN M4—

Recent AVIR Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AVIR insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

AVIR Insider Trading — FAQ

What is the latest insider trade for AVIR?
Atea Pharmaceuticals, Inc. (AVIR) had 10 insider filings in the last 90 days, with the most recent on 2026-06-23. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying AVIR stock?
0 insider purchases of AVIR were filed in the last 90 days.
How many insiders are selling AVIR stock?
0 insider sales of AVIR were filed in the last 90 days.
Where can I see AVIR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every AVIR SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live AVIR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.